: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

Your Kind of Day?

Thu, 05 Nov 2009 19:06:48 GMT

As a rule, I try not to read too terribly much into a "Fed Day" as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on "Fed Days." But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.[More...]

The Dollar-Proof Portfolio

Thu, 05 Nov 2009 17:31:14 GMT

Don't put off this important piece of the financial-planning process.[More...]

What Investors Should Look for In Today’s Fed Statement

Wed, 04 Nov 2009 13:04:24 GMT

In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).[More...]

Are Discount Brokers Shares Worth Owning?

Wed, 04 Nov 2009 01:28:03 GMT

The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&P gain 15%.[More...]

Technology Rises And Buying Facebook

Tue, 03 Nov 2009 16:54:11 GMT

Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%. Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.[More...]

Buffett Gets His Cheque Book Out

Tue, 03 Nov 2009 16:17:34 GMT

Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.[More...]

Five Ways To Ride The Commodities Bull

Tue, 03 Nov 2009 15:21:07 GMT

Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over. Don’t believe it.[More...]

Inspire reports $8.5 million 3Q loss

Fri, 06 Nov 2009 17:48:00 GMT

Nov. 6--DURHAM -- Inspire Pharmaceuticals Inc. on Thursday reported a loss of $8.5 million for the third quarter, mostly owing to an increase in expenses even as revenues for the company's lead products rose.
Operating expenses for the third quarter totaled $33.1 million, up from $29 million a year ago, primarily because of higher research and development expenses, including a $3.3 million milestone payment to Yamasa Corp. for a technology agreement to enable a two-supplier strategy for denufosol, the company's candidate for treating cystic fibrosis.
Revenue from Azasite, the company's candidate for treating pinkeye, was $9.0 million, nearly double the $4.7 million from the third quarter of 2008.

: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Your Kind of Day?

The Dollar-Proof Portfolio

What Investors Should Look for In Today’s Fed Statement

Are Discount Brokers Shares Worth Owning?

Technology Rises And Buying Facebook

Buffett Gets His Cheque Book Out

Five Ways To Ride The Commodities Bull

Inspire reports $8.5 million 3Q loss

Allergan Wins Patent Infringement Lawsuit Against Exela and Apotex

Allergan Q2 Net Earnings Up

FDA orders botulinum toxin warnings

Correction: Allergan story

Nightly Business Report - Mar 21 2009 5:53AM

Midday Dividend Scan: Commercial Metals - Twelve Cents; CTS - $0.03; Heinz - 41.5 cents; Medicis - $0.04; Staples - $0.0825

Jobless Claims Tally Highest Since 1982

Jobless Rate Still Up; Sales Still Weak

Botox Sales Sag, Surprising Maker Allergan Thought Recession Wouldn't Affect Wrinkle Shots

Phase Forward Reports Third Quarter 2009 Results

Allergan Announces Victory in Brimonidine Patent Infringement Case

Licensing Executives Society Announces 2009 Deals of Distinction Awards

RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on MRX, RPM, BKE, NMR, BLL and SSL

SYSPRO Honored for Business Excellence

Investment Industry Regulatory Organization of Canada - Trade Resumption - ICS Copper Systems Ltd. - ICX

ICS finds JV partner

BenchmarkJournal.Com Free Analyst Review for ACN, CHL, L, AGN, BA and AMX

Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009

Spectrum Pharmaceuticals Announces Second Quarter 2009 Corporate Update

Form 4 GALLAGHER MICHAEL R For: Nov 03 (10K)

Form 4 INGRAM DOUGLAS S For: Nov 03 (10K)

Form 4 GALLAGHER MICHAEL R For: Oct 27 (10K)

Form 4 BOYER HERBERT W PH D For: Oct 01 (10K)

Form 4 ALLERGAN INC For: Sep 28 Filed by: INGRAM ROBERT ALEXANDER (10K)

Form 4 GALLAGHER MICHAEL R For: Sep 28 (10K)

Form 4 Dunsire Deborah For: Sep 28 (10K)

Form 4 BOYER HERBERT W PH D For: Sep 28 (10K)

Form 4 HERBERT GAVIN S For: Sep 16 (10K)

Form 4 Whitcup Scott M For: Sep 16 (10K)